Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

247
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
247
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

442
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
442
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

3.1K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
3.1K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

297
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
297
Tumor Immunotherapy01:27

Tumor Immunotherapy

524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

scRNA-seq and genomics analyses reveal key mechanisms of inverted papilloma-associated sinonasal squamous cell carcinoma malignant transformation.

bioRxiv : the preprint server for biology·2026
Same author

3D Volumetric-Based resection modeling to optimize reconstructive outcomes for ablative oral cavity defects.

Oral oncology·2026
Same author

Measurement Tools for Radiation-Induced Fibrosis in Head and Neck Cancer: A Systematic Review.

Head & neck·2026
Same author

Preoperative Neutrophil-to-Lymphocyte Ratio Predicts Recurrence in HPV-Associated Oropharyngeal Cancer After Transoral Robotic Surgery.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery·2026
Same author

Graduated autonomy in head and neck microvascular surgery fellowship training: oncologic and reconstructive competency, safety, and educational implications.

Current opinion in otolaryngology & head and neck surgery·2026
Same author

Cardiovascular adverse events associated with bispecific antibodies in relapsed or refractory B-cell non-Hodgkin lymphomas.

Journal of hematology & oncology·2026
Same journal

Real-Time Light-Guided Vocal Fold Injection for Unilateral Vocal Fold Paralysis: Experience From 378 Consecutive Cases.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery·2026
Same journal

Preoperatively Diagnosed Versus Undiagnosed Major Salivary Gland Cancer: Clinicopathological Characteristics, Treatment Strategies, and Oncological Outcomes.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery·2026
Same journal

Estimating Performance Using Tonotopic Measurements of Intracochlear Electrocochleography: Comparison of Lateral Wall and Perimodiolar Arrays.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery·2026
Same journal

Head and Neck Free Flap Reconstruction: Current Landscape and Emerging Technologies.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery·2026
Same journal

GLP-1 Receptor Agonist Effect on Disease Severity in Idiopathic Subglottic Stenosis.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery·2026
Same journal

Congenital Intraoral Synechiae: A Scoping Review of Airway, Feeding, and Surgical Management.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery·2026
See all related articles

Related Experiment Video

Updated: Jul 2, 2025

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

2.4K

Clinical Practice Guideline: Immunotherapy for Inhalant Allergy.

Richard K Gurgel1, Fuad M Baroody2, Cecelia C Damask3

  • 1University of Utah, Salt Lake City, Utah, USA.

Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery
|February 26, 2024
PubMed
Summary
This summary is machine-generated.

Allergen immunotherapy (AIT) offers a way to manage allergic rhinitis and asthma by inducing tolerance. This guideline provides evidence-based recommendations for safe and effective AIT initiation and delivery for improved patient care.

Keywords:
allergen immunotherapyallergic asthmaallergic rhinitisanaphylaxisinhalant allergysubcutaneous immunotherapysublingual immunotherapy

More Related Videos

Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

8.2K
Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
16:56

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

17.0K

Related Experiment Videos

Last Updated: Jul 2, 2025

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

2.4K
Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

8.2K
Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
16:56

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

17.0K

Area of Science:

  • Allergy and Immunology
  • Clinical Practice Guidelines
  • Immunotherapy

Background:

  • Allergen immunotherapy (AIT) is a widely used treatment for allergic rhinitis (AR) and allergic asthma (AA).
  • Subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT) are common delivery methods.
  • Variability exists in AIT initiation and delivery, necessitating evidence-based recommendations for optimal patient care.

Purpose of the Study:

  • To identify quality improvement opportunities in inhaled allergen immunotherapy (AIT).
  • To provide clinicians with evidence-based recommendations for managing inhaled allergies with AIT.
  • To optimize patient care, promote safety and efficacy, reduce care variations, and minimize harm.

Main Methods:

  • Development of a clinical practice guideline (CPG) by a guideline development group (GDG).
  • Focus on evidence-based quality improvement opportunities.
  • Recommendations based on clinical assessment, allergy testing, and patient factors.

Main Results:

  • Strong recommendation for clinicians to diagnose and manage anaphylaxis during AIT.
  • Recommendations for offering AIT for inadequately controlled AR/AA, patient education on SCIT/SLIT, and appropriate allergen selection.
  • Guidance on managing local reactions, duration of treatment, and contraindications for initiating AIT.

Conclusions:

  • Clinicians should offer AIT to eligible patients with AR/AA.
  • Patient education and careful assessment for contraindications are crucial for safe and effective AIT.
  • A minimum treatment duration of 3 years is recommended for symptomatic control.